世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
人工授精市場。世界の産業動向、シェア、サイズ、成長、機会、予測2021-2026年Artificial Insemination Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026 The global artificial insemination market reached a value of US$ 2,034 Million in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 8.5% during 2021-2026. Keeping in mind t... もっと見る
サマリーThe global artificial insemination market reached a value of US$ 2,034 Million in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 8.5% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.Artificial insemination is an assisted reproductive treatment wherein semen with living sperms is introduced into the cervix, fallopian tubes, or uterus of a female. It is performed via artificial insemination homologous (AIH) or artificial insemination donor semen (AID) procedures that are short and relatively painless. Self-insemination kits are nowadays available in the market that can be used at the convenience of home. At present, artificial insemination is widely being used in animal breeding to facilitate the reproductive success and conservation of threatened or endangered species. It also prevents the spread of certain diseases and sterility due to genital conditions in animals. Artificial Insemination Market Trends: The rising infertility rates, along with the increasing awareness among individuals about alternative reproductive treatments, represent one of the significant factors influencing the market. Moreover, governments of numerous countries have legalized same-sex marriage and are providing insurance coverage to civil unions for artificial insemination procedures, which is also contributing to the market growth. Apart from this, the rising global population and the escalating demand for animal-based protein are fueling the need for artificial insemination among domestic livestock animals. Improving veterinary services and rising expenditure on animal healthcare is also supporting the market growth. Furthermore, the leading players are entering into strategic collaborations for expanding their portfolio of animal genetic and strengthening their position in different markets. For instance, Genus plc, which is a leading animal genetics company, partnered with Beijing Capital Agribusiness Co. Ltd, a leading Chinese animal protein genetics business, to research and develop virus-resistant techniques in pigs. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global artificial insemination market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on type, source type and end use. Breakup by Type: Intrauterine Intracervical Intravaginal Intratubal Breakup by Source Type: AIH-Husband AID-Donor Breakup by End Use: Hospitals and Clinics Fertility Centers Others Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being Conceivex Inc., FUJIFILM Irvine Scientific Inc. (Fujifilm Holdings Corporation), Genea Limited, Genus plc, Hamilton Thorne Inc., Hi-Tech Solutions, Kitazato Corporation, Pride Angel, Rinovum Women’s Health LLC, Rocket Medical plc, TenderNeeds Fertility LLC and Vitrolife AB. Key Questions Answered in This Report: How has the global artificial insemination market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global artificial insemination market? What are the key regional markets? What is the breakup of the market based on the type? What is the breakup of the market based on the source type? What is the breakup of the market based on the end use? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global artificial insemination market and who are the key players? What is the degree of competition in the industry? 目次1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Artificial Insemination Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Type 6.1 Intrauterine 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Intracervical 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Intravaginal 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Intratubal 6.4.1 Market Trends 6.4.2 Market Forecast 7 Market Breakup by Source Type 7.1 AIH-Husband 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 AID-Donor 7.2.1 Market Trends 7.2.2 Market Forecast 8 Market Breakup by End Use 8.1 Hospitals and Clinics 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Fertility Centers 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Others 8.3.1 Market Trends 8.3.2 Market Forecast 9 Market Breakup by Region 9.1 North America 9.1.1 United States 9.1.1.1 Market Trends 9.1.1.2 Market Forecast 9.1.2 Canada 9.1.2.1 Market Trends 9.1.2.2 Market Forecast 9.2 Asia-Pacific 9.2.1 China 9.2.1.1 Market Trends 9.2.1.2 Market Forecast 9.2.2 Japan 9.2.2.1 Market Trends 9.2.2.2 Market Forecast 9.2.3 India 9.2.3.1 Market Trends 9.2.3.2 Market Forecast 9.2.4 South Korea 9.2.4.1 Market Trends 9.2.4.2 Market Forecast 9.2.5 Australia 9.2.5.1 Market Trends 9.2.5.2 Market Forecast 9.2.6 Indonesia 9.2.6.1 Market Trends 9.2.6.2 Market Forecast 9.2.7 Others 9.2.7.1 Market Trends 9.2.7.2 Market Forecast 9.3 Europe 9.3.1 Germany 9.3.1.1 Market Trends 9.3.1.2 Market Forecast 9.3.2 France 9.3.2.1 Market Trends 9.3.2.2 Market Forecast 9.3.3 United Kingdom 9.3.3.1 Market Trends 9.3.3.2 Market Forecast 9.3.4 Italy 9.3.4.1 Market Trends 9.3.4.2 Market Forecast 9.3.5 Spain 9.3.5.1 Market Trends 9.3.5.2 Market Forecast 9.3.6 Russia 9.3.6.1 Market Trends 9.3.6.2 Market Forecast 9.3.7 Others 9.3.7.1 Market Trends 9.3.7.2 Market Forecast 9.4 Latin America 9.4.1 Brazil 9.4.1.1 Market Trends 9.4.1.2 Market Forecast 9.4.2 Mexico 9.4.2.1 Market Trends 9.4.2.2 Market Forecast 9.4.3 Others 9.4.3.1 Market Trends 9.4.3.2 Market Forecast 9.5 Middle East and Africa 9.5.1 Market Trends 9.5.2 Market Breakup by Country 9.5.3 Market Forecast 10 SWOT Analysis 10.1 Overview 10.2 Strengths 10.3 Weaknesses 10.4 Opportunities 10.5 Threats 11 Value Chain Analysis 12 Porters Five Forces Analysis 12.1 Overview 12.2 Bargaining Power of Buyers 12.3 Bargaining Power of Suppliers 12.4 Degree of Competition 12.5 Threat of New Entrants 12.6 Threat of Substitutes 13 Price Analysis 14 Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players 14.3.1 Conceivex Inc. 14.3.1.1 Company Overview 14.3.1.2 Product Portfolio 14.3.2 FUJIFILM Irvine Scientific Inc. (Fujifilm Holdings Corporation) 14.3.2.1 Company Overview 14.3.2.2 Product Portfolio 14.3.3 Genea Limited 14.3.3.1 Company Overview 14.3.3.2 Product Portfolio 14.3.4 Genus plc 14.3.4.1 Company Overview 14.3.4.2 Product Portfolio 14.3.4.3 Financials 14.3.4.4 SWOT Analysis 14.3.5 Hamilton Thorne Inc. 14.3.5.1 Company Overview 14.3.5.2 Product Portfolio 14.3.5.3 Financials 14.3.6 Hi-Tech Solutions 14.3.6.1 Company Overview 14.3.6.2 Product Portfolio 14.3.7 Kitazato Corporation 14.3.7.1 Company Overview 14.3.7.2 Product Portfolio 14.3.8 Pride Angel 14.3.8.1 Company Overview 14.3.8.2 Product Portfolio 14.3.9 Rinovum Women’s Health LLC 14.3.9.1 Company Overview 14.3.9.2 Product Portfolio 14.3.10 Rocket Medical plc 14.3.10.1 Company Overview 14.3.10.2 Product Portfolio 14.3.11 TenderNeeds Fertility LLC 14.3.11.1 Company Overview 14.3.11.2 Product Portfolio 14.3.12 Vitrolife AB 14.3.12.1 Company Overview 14.3.12.2 Product Portfolio 14.3.12.3 Financials
SummaryThe global artificial insemination market reached a value of US$ 2,034 Million in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 8.5% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.Artificial insemination is an assisted reproductive treatment wherein semen with living sperms is introduced into the cervix, fallopian tubes, or uterus of a female. It is performed via artificial insemination homologous (AIH) or artificial insemination donor semen (AID) procedures that are short and relatively painless. Self-insemination kits are nowadays available in the market that can be used at the convenience of home. At present, artificial insemination is widely being used in animal breeding to facilitate the reproductive success and conservation of threatened or endangered species. It also prevents the spread of certain diseases and sterility due to genital conditions in animals. Artificial Insemination Market Trends: The rising infertility rates, along with the increasing awareness among individuals about alternative reproductive treatments, represent one of the significant factors influencing the market. Moreover, governments of numerous countries have legalized same-sex marriage and are providing insurance coverage to civil unions for artificial insemination procedures, which is also contributing to the market growth. Apart from this, the rising global population and the escalating demand for animal-based protein are fueling the need for artificial insemination among domestic livestock animals. Improving veterinary services and rising expenditure on animal healthcare is also supporting the market growth. Furthermore, the leading players are entering into strategic collaborations for expanding their portfolio of animal genetic and strengthening their position in different markets. For instance, Genus plc, which is a leading animal genetics company, partnered with Beijing Capital Agribusiness Co. Ltd, a leading Chinese animal protein genetics business, to research and develop virus-resistant techniques in pigs. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global artificial insemination market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on type, source type and end use. Breakup by Type: Intrauterine Intracervical Intravaginal Intratubal Breakup by Source Type: AIH-Husband AID-Donor Breakup by End Use: Hospitals and Clinics Fertility Centers Others Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being Conceivex Inc., FUJIFILM Irvine Scientific Inc. (Fujifilm Holdings Corporation), Genea Limited, Genus plc, Hamilton Thorne Inc., Hi-Tech Solutions, Kitazato Corporation, Pride Angel, Rinovum Women’s Health LLC, Rocket Medical plc, TenderNeeds Fertility LLC and Vitrolife AB. Key Questions Answered in This Report: How has the global artificial insemination market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global artificial insemination market? What are the key regional markets? What is the breakup of the market based on the type? What is the breakup of the market based on the source type? What is the breakup of the market based on the end use? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global artificial insemination market and who are the key players? What is the degree of competition in the industry? Table of Contents1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Artificial Insemination Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Type 6.1 Intrauterine 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Intracervical 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Intravaginal 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Intratubal 6.4.1 Market Trends 6.4.2 Market Forecast 7 Market Breakup by Source Type 7.1 AIH-Husband 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 AID-Donor 7.2.1 Market Trends 7.2.2 Market Forecast 8 Market Breakup by End Use 8.1 Hospitals and Clinics 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Fertility Centers 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Others 8.3.1 Market Trends 8.3.2 Market Forecast 9 Market Breakup by Region 9.1 North America 9.1.1 United States 9.1.1.1 Market Trends 9.1.1.2 Market Forecast 9.1.2 Canada 9.1.2.1 Market Trends 9.1.2.2 Market Forecast 9.2 Asia-Pacific 9.2.1 China 9.2.1.1 Market Trends 9.2.1.2 Market Forecast 9.2.2 Japan 9.2.2.1 Market Trends 9.2.2.2 Market Forecast 9.2.3 India 9.2.3.1 Market Trends 9.2.3.2 Market Forecast 9.2.4 South Korea 9.2.4.1 Market Trends 9.2.4.2 Market Forecast 9.2.5 Australia 9.2.5.1 Market Trends 9.2.5.2 Market Forecast 9.2.6 Indonesia 9.2.6.1 Market Trends 9.2.6.2 Market Forecast 9.2.7 Others 9.2.7.1 Market Trends 9.2.7.2 Market Forecast 9.3 Europe 9.3.1 Germany 9.3.1.1 Market Trends 9.3.1.2 Market Forecast 9.3.2 France 9.3.2.1 Market Trends 9.3.2.2 Market Forecast 9.3.3 United Kingdom 9.3.3.1 Market Trends 9.3.3.2 Market Forecast 9.3.4 Italy 9.3.4.1 Market Trends 9.3.4.2 Market Forecast 9.3.5 Spain 9.3.5.1 Market Trends 9.3.5.2 Market Forecast 9.3.6 Russia 9.3.6.1 Market Trends 9.3.6.2 Market Forecast 9.3.7 Others 9.3.7.1 Market Trends 9.3.7.2 Market Forecast 9.4 Latin America 9.4.1 Brazil 9.4.1.1 Market Trends 9.4.1.2 Market Forecast 9.4.2 Mexico 9.4.2.1 Market Trends 9.4.2.2 Market Forecast 9.4.3 Others 9.4.3.1 Market Trends 9.4.3.2 Market Forecast 9.5 Middle East and Africa 9.5.1 Market Trends 9.5.2 Market Breakup by Country 9.5.3 Market Forecast 10 SWOT Analysis 10.1 Overview 10.2 Strengths 10.3 Weaknesses 10.4 Opportunities 10.5 Threats 11 Value Chain Analysis 12 Porters Five Forces Analysis 12.1 Overview 12.2 Bargaining Power of Buyers 12.3 Bargaining Power of Suppliers 12.4 Degree of Competition 12.5 Threat of New Entrants 12.6 Threat of Substitutes 13 Price Analysis 14 Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players 14.3.1 Conceivex Inc. 14.3.1.1 Company Overview 14.3.1.2 Product Portfolio 14.3.2 FUJIFILM Irvine Scientific Inc. (Fujifilm Holdings Corporation) 14.3.2.1 Company Overview 14.3.2.2 Product Portfolio 14.3.3 Genea Limited 14.3.3.1 Company Overview 14.3.3.2 Product Portfolio 14.3.4 Genus plc 14.3.4.1 Company Overview 14.3.4.2 Product Portfolio 14.3.4.3 Financials 14.3.4.4 SWOT Analysis 14.3.5 Hamilton Thorne Inc. 14.3.5.1 Company Overview 14.3.5.2 Product Portfolio 14.3.5.3 Financials 14.3.6 Hi-Tech Solutions 14.3.6.1 Company Overview 14.3.6.2 Product Portfolio 14.3.7 Kitazato Corporation 14.3.7.1 Company Overview 14.3.7.2 Product Portfolio 14.3.8 Pride Angel 14.3.8.1 Company Overview 14.3.8.2 Product Portfolio 14.3.9 Rinovum Women’s Health LLC 14.3.9.1 Company Overview 14.3.9.2 Product Portfolio 14.3.10 Rocket Medical plc 14.3.10.1 Company Overview 14.3.10.2 Product Portfolio 14.3.11 TenderNeeds Fertility LLC 14.3.11.1 Company Overview 14.3.11.2 Product Portfolio 14.3.12 Vitrolife AB 14.3.12.1 Company Overview 14.3.12.2 Product Portfolio 14.3.12.3 Financials
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野の最新刊レポート
IMARC Services Private Limited.社のその他分野での最新刊レポート
本レポートと同じKEY WORD（artificial）の最新刊レポート
よくあるご質問IMARC Services Private Limited.社はどのような調査会社ですか?インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/27 10:26 153.88 円 161.83 円 196.22 円 |
